Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives
Krečak, I., Verstovsek, S. i Lucijanić, M. (2023). Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives. Annals of Hematology, 103. (5), 1513-1523. doi: 10.1007/s00277-023-05426-9
Krečak, Ivan, et al. "Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives." Annals of Hematology, vol. 103, br. 5, 2023, str. 1513-1523. https://doi.org/10.1007/s00277-023-05426-9
Krečak, Ivan, Srdan Verstovsek i Marko Lucijanić. "Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives." Annals of Hematology 103, br. 5 (2023): 1513-1523. https://doi.org/10.1007/s00277-023-05426-9
Krečak, I., Verstovsek, S. i Lucijanić, M. (2023) 'Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives', Annals of Hematology, 103(5), str. 1513-1523. doi: 10.1007/s00277-023-05426-9
Krečak I, Verstovsek S, Lucijanić M. Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives. Annals of Hematology [Internet]. 04.09.2023. [pristupljeno 05.10.2024.];103(5):1513-1523. doi: 10.1007/s00277-023-05426-9
I. Krečak, S. Verstovsek i M. Lucijanić, "Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives", Annals of Hematology, vol. 103, br. 5, str. 1513-1523, Rujan 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:613579. [Citirano: 05.10.2024.]